hepatocellular carcinoma
Conditions
Interventions
Group A:percutaneous radiofrequency ablation
Group B:open radiofrequency ablation
Sponsors
West China Hospital, Sichuan University, Chengdu, China
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. confirmed diagnosis of recurrent HCC by EASL2000 after surgical resection, no extrahepatic metastasis, single lesion smaller than 5cm in diameter, up to 3 lesions smaller than 3 cm each; 2. absence of coagulopathy: a platelet count >50*10^9/L or correctable by platelet transfusion, a prothrombin time prolongation less than 5 seconds; 3. liver function of Child-Pugh Class A or B; 4. absence of refractory ascites or moderate-severe gastric esophageal varicose; 5. no large vascular or nearby organ invasion; 6. no previous or simultaneous malignancies.
Exclusion criteria
Exclusion criteria: 1. patients refuse or no indication,such as tumor in porta hepatis; 2. patients suffering from other malignancies; 3. patients with active HBV or HCV.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| tumor free survival rate;survival rate;recurrence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| complication; | — |
Countries
China
Contacts
Public ContactZeng Yong
Outcome results
None listed